Search Within

Michael Andrew Postow

  1. "Biostatistics Service"
Formats
  1. Journal Article (46)
  2. Meeting Abstract (30)
  3. Research Letter (2)
Groups
  1. Biostatistics Service (78)
  2. Department of Medicine (78)
  3. Epidemiology and Biostatistics (78)
  4. Melanoma Disease Management Team (78)
  5. Melanoma and Immunotherapeutics Service (78)
  6. Solid Tumor Oncology Division (78)

More Groups

People
  1. Katherine Panageas (64)
  2. Jedd Wolchok (45)
  3. Alexander Shoushtari (35)
  4. Margaret Callahan (33)
  5. Paul Chapman (31)
  6. Parisa Momtaz (25)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (8)
  5. 2021 (8)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Annals of Surgical Oncology (5)
  3. Journal for ImmunoTherapy of Cancer (5)
  4. The Oncologist (5)
  5. Clinical Cancer Research (4)
  6. JAMA Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (6)
  4. Biomed Central Ltd (5)
  5. Nature Publishing Group (5)
  6. Springer (5)

More Publishers

Results (78)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
    Journal Article

    Bartlett, E. K.; Flynn, J. R.; Panageas, K. S.; Ferraro, R. A.; Sta.Cruz, J. M.; Postow, M. A.; Coit, D. G.; Ariyan, C. E.
    Cancer (2020)

    Fulltext@MSK | Save
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma
    Meeting Abstract

    Postow, M. A.; Knox, S. J.; Goldman, D.; Panageas, K.; Halpenny, D.; McCabe, D.; Macri, M. J.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • Computed tomography-derived assessments of regional muscle volume: Validating their use as predictors of whole body muscle volume in cancer patients
    Journal Article

    Halpenny, D. F.; Goncalves, M.; Schwitzer, E.; Golia Pernicka, J.; Jackson, J.; Gandelman, S.; Moskowitz, C. S.; Postow, M.; Mourtzakis, M.; Caan, B.; more...
    British Journal of Radiology (2018)

    Fulltext@MSK | Save
  • A phase 1 clinical trial of ipilimumab, nivolumab and radiation therapy for patients with metastatic melanoma
    Meeting Abstract

    Barker, C. A.; Postow, M. A.; Goldman, D. A.; Panageas, K. S.; Halpenny, D.; McCabe, D.; Macri, M.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy
    Meeting Abstract

    Bello, D. M.; Panageas, K. S.; Hollmann, T. J.; Shoushtari, A. N.; Chapman, P.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; Coit, D.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save